Simplex Trading
DMAC icon

Simplex Trading’s DiaMedica Therapeutics DMAC Stock Holding History

Simplex Trading’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,132
Closed -$96.1K – 9294
2025
Q4 		$96.6K Buy
12,132
+10,056
+484% +$75.2K ﹤0.01% 5033
2025
Q3 		$14K Buy
+2,076
New +$11.3K ﹤0.01% 7627
2025
Q2 		– Sell
-374
Closed -$1.46K – 8866
2025
Q1 		$1K Buy
+374
New +$2.14K ﹤0.01% 8182
2024
Q4 		– Sell
-3,662
Closed -$17.3K – 8720
2024
Q3 		$15K Buy
+3,662
New +$13.5K ﹤0.01% 6880
2024
Q1 		– Sell
-481
Closed -$1.4K – 9039
2023
Q4 		$1K Sell
481
-539
-53% -$1.33K ﹤0.01% 8462
2023
Q3 		$2K Buy
1,020
+818
+405% +$2.63K ﹤0.01% 8068
2023
Q2 		$0 Sell
202
-3,324
-94% -$8.07K ﹤0.01% 9164
2023
Q1 		$5K Sell
3,526
-1,037
-23% -$1.65K ﹤0.01% 8025
2022
Q4 		$7K Buy
4,563
+2,558
+128% +$3.44K ﹤0.01% 7813
2022
Q3 		$2K Buy
+2,005
New +$3.13K ﹤0.01% 9256
2022
Q1 		– Sell
-6,350
Closed -$18K – 10573
2021
Q4 		$23K Sell
6,350
-9,991
-61% -$39.2K ﹤0.01% 8189
2021
Q3 		$70K Sell
16,341
-100
-0.6% -$383 ﹤0.01% 7081
2021
Q2 		$73K Buy
16,441
+16,187
+6,373% +$133K ﹤0.01% 7166
2021
Q1 		$2K Buy
+254
New +$2.37K ﹤0.01% 8441

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Simplex Trading's DMAC Position: Q1 2026 in Review

Simplex Trading sold out of DiaMedica Therapeutics (DMAC) in Q1 2026, closing a stake of 12,132 shares — an estimated $96.1K sold.

Simplex Trading first reported a position in DMAC in Q1 2021 and held it in 14 quarters. The position peaked at $96.6K in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Simplex Trading reported no remaining DiaMedica Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 12,132 DiaMedica Therapeutics shares in Q1 2026, an estimated $96.1K.
  • Simplex Trading first reported a position in DiaMedica Therapeutics in Q1 2021 and held it in 14 quarters.
  • Simplex Trading's DiaMedica Therapeutics position peaked at $96.6K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.